tradingkey.logo

Resmed Inc

RMD
查看詳細走勢圖
255.196USD
-4.083-1.57%
交易中 美東報價延遲15分鐘
37.24B總市值
26.01本益比TTM

Resmed Inc

255.196
-4.083-1.57%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-1.57%

5天

-1.66%

1月

+4.19%

6月

-2.25%

今年開始到現在

+5.95%

1年

+2.99%

查看詳細走勢圖

TradingKey Resmed Inc股票評分

單位: USD 更新時間: 2026-01-21

操作建議

Resmed Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名13/206位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為291.90。中期看,股價處於平穩狀態。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Resmed Inc評分

相關信息

行業排名
13 / 206
全市場排名
68 / 4548
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Resmed Inc亮點

亮點風險
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
業績高增長
公司營業收入穩步增長,連續3年增長21.86%
利潤高增長
公司淨利潤處於行業前列,最新年度總收入5.15B美元
高分紅
公司屬於高分紅公司,最新股息支付率22.19%
穩定分紅
公司5年內持續分紅,最新股息支付率22.19%
估值低估
公司最新PE估值26.43,處於3年歷史低位
機構減倉
最新機構持股95.97M股,環比減少1.42%
ETHSX持倉
明星投資者ETHSX持倉,最新持倉17.10K股

分析師目標

基於 21 分析師
買入
評級
291.897
目標均價
+13.32%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Resmed Inc簡介

ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
公司代碼RMD
公司Resmed Inc
CEOFarrell (Michael J)
網址https://www.resmed.com/

常見問題

Resmed Inc(RMD)的當前股價是多少?

Resmed Inc(RMD)的當前股價是 255.196。

Resmed Inc 的股票代碼是什麼?

Resmed Inc的股票代碼是RMD。

Resmed Inc股票的52週最高點是多少?

Resmed Inc股票的52週最高點是293.810。

Resmed Inc股票的52週最低點是多少?

Resmed Inc股票的52週最低點是199.920。

Resmed Inc的市值是多少?

Resmed Inc的市值是37.24B。

Resmed Inc的淨利潤是多少?

Resmed Inc的淨利潤為1.40B。

現在Resmed Inc(RMD)的股票是買入、持有還是賣出?

根據分析師評級,Resmed Inc(RMD)的總體評級為買入,目標價格為291.897。

Resmed Inc(RMD)股票的每股收益(EPS TTM)是多少

Resmed Inc(RMD)股票的每股收益(EPS TTM)是9.811。
KeyAI